Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Pharmacokinetics and Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Single 'High' Doses of Rifampicin in Healthy Volunteers

NCT02387242 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT02387242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02387242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Pharmacokinetics and Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Single 'High' Doses of Rifampicin in Healthy Volunteers
Lead sponsor
National University Hospital, Singapore
Phase
Phase 1
Overall status
Suspended
Start date
February 28, 2015
Completion date
December 31, 2017
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis